These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 25059503

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Furanylazaindoles: potent anticancer agents in vitro and in vivo.
    Lee HY, Pan SL, Su MC, Liu YM, Kuo CC, Chang YT, Wu JS, Nien CY, Mehndiratta S, Chang CY, Wu SY, Lai MJ, Chang JY, Liou JP.
    J Med Chem; 2013 Oct 24; 56(20):8008-18. PubMed ID: 24106982
    [Abstract] [Full Text] [Related]

  • 3. 7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents.
    Chang JY, Hsieh HP, Chang CY, Hsu KS, Chiang YF, Chen CM, Kuo CC, Liou JP.
    J Med Chem; 2006 Nov 16; 49(23):6656-9. PubMed ID: 17154496
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
    Wang G, Li C, He L, Lei K, Wang F, Pu Y, Yang Z, Cao D, Ma L, Chen J, Sang Y, Liang X, Xiang M, Peng A, Wei Y, Chen L.
    Bioorg Med Chem; 2014 Apr 01; 22(7):2060-79. PubMed ID: 24629450
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
    Liou JP, Wu CY, Hsieh HP, Chang CY, Chen CM, Kuo CC, Chang JY.
    J Med Chem; 2007 Sep 06; 50(18):4548-52. PubMed ID: 17685504
    [Abstract] [Full Text] [Related]

  • 8. New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors.
    La Regina G, Bai R, Coluccia A, Naccarato V, Famiglini V, Nalli M, Masci D, Verrico A, Rovella P, Mazzoccoli C, Da Pozzo E, Cavallini C, Martini C, Vultaggio S, Dondio G, Varasi M, Mercurio C, Hamel E, Lavia P, Silvestri R.
    Eur J Med Chem; 2018 May 25; 152():283-297. PubMed ID: 29730191
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, anti-cancer evaluation of benzenesulfonamide derivatives as potent tubulin-targeting agents.
    Yang J, Yang S, Zhou S, Lu D, Ji L, Li Z, Yu S, Meng X.
    Eur J Med Chem; 2016 Oct 21; 122():488-496. PubMed ID: 27423028
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and pharmacological evaluation of N-(3-(1H-indol-4-yl)-5-(2-methoxyisonicotinoyl)phenyl)methanesulfonamide (LP-261), a potent antimitotic agent.
    Shetty RS, Lee Y, Liu B, Husain A, Joseph RW, Lu Y, Nelson D, Mihelcic J, Chao W, Moffett KK, Schumacher A, Flubacher D, Stojanovic A, Bukhtiyarova M, Williams K, Lee KJ, Ochman AR, Saporito MS, Moore WR, Flynn GA, Dorsey BD, Springman EB, Fujimoto T, Kelly MJ.
    J Med Chem; 2011 Jan 13; 54(1):179-200. PubMed ID: 21126027
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Promising anti-proliferative indolic benzenesulfonamides alter mechanisms with sulfonamide nitrogen substituents.
    Fuentes-Martín R, Ayuda-Durán P, Hanes R, Gallego-Yerga L, Wolterinck L, Enserink JM, Álvarez R, Peláez R.
    Eur J Med Chem; 2024 Sep 05; 275():116617. PubMed ID: 38959729
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents.
    Liu Y, Wei D, Zhao Y, Cheng W, Lu Y, Ma Y, Li X, Han C, Wei Y, Cao H, Zhao C.
    Bioorg Med Chem; 2012 Nov 01; 20(21):6285-95. PubMed ID: 23022053
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis, and biological evaluation of cyclic-indole derivatives as anti-tumor agents via the inhibition of tubulin polymerization.
    Yan J, Hu J, An B, Huang L, Li X.
    Eur J Med Chem; 2017 Jan 05; 125():663-675. PubMed ID: 27721152
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and structure-activity relationships of N-methyl-5,6,7-trimethoxylindoles as novel antimitotic and vascular disrupting agents.
    Zhao DG, Chen J, Du YR, Ma YY, Chen YX, Gao K, Hu BR.
    J Med Chem; 2013 Feb 28; 56(4):1467-77. PubMed ID: 23360369
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and biological evaluation of novel indole-pyrimidine hybrids bearing morpholine and thiomorpholine moieties.
    Diao PC, Li Q, Hu MJ, Ma YF, You WW, Hong KH, Zhao PL.
    Eur J Med Chem; 2017 Jul 07; 134():110-118. PubMed ID: 28410492
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and structure-activity relationship of 4-azaheterocycle benzenesulfonamide derivatives as new microtubule-targeting agents.
    Yang J, Zhou S, Ji L, Zhang C, Yu S, Li Z, Meng X.
    Bioorg Med Chem Lett; 2014 Nov 01; 24(21):5055-8. PubMed ID: 25278233
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis, and biological evaluation of novel N-γ-carboline arylsulfonamides as anticancer agents.
    Chen J, Liu T, Wu R, Lou J, Cao J, Dong X, Yang B, He Q, Hu Y.
    Bioorg Med Chem; 2010 Dec 15; 18(24):8478-84. PubMed ID: 21067933
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.